Endometrial Cancer Trial, Recruiting NCT06078514 Sponsor: Tampere University Hospital Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT06078514
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 70 years old
  • People attending their first colposcopy appointment, or whose last colposcopy was more than 24 months ago
  • People referred for the colposcopy due to abnormal cervical screening results or repeated positive HPV test results
  • People who have not previously had a LEEP procedure or any other surgery that may have affected the length of the cervix
  • People who are not pregnant at the time of the colposcopy or LEEP procedure
  • People who are sexually active
  • People who are able to understand the study procedures and have given informed consent to participate
  • People who are fluent in Finnish

Who may not be able to join:

  • People younger than 18 or older than 70 years of age
  • People who have had a colposcopy within the last 24 months
  • People referred for a reason other than abnormal cervical screening or HPV results, such as a vulvar lesion
  • People who have previously had a LEEP procedure or other surgery affecting the length of the cervix
  • People who are pregnant at the time of the colposcopy or LEEP procedure
  • People who are not sexually active
  • People who are unable to understand the study procedures or are unable to give informed consent
  • People who have difficulty understanding Finnish

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Laura Kotaniemi-Talonen, PhD, Tampere University Hospital

Phone: +358 3 311 66008

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tampere University Hospital
Registry
ClinicalTrials.gov
Start date
2 May 2024
Est. completion
1 December 2028

Where this trial is recruiting

🇫🇮 Finland

Primary endpoints

Self-reported sexual function measured by Female Sexual Function Index (FSFI); Self-reported health-related quality of life measured by 15D

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov